# School-Based Treatment With ACT to Reduce Transmission

> **NCT02009215** · PHASE4 · COMPLETED · sponsor: **London School of Hygiene and Tropical Medicine** · enrollment: 10746 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Dihydroartemisinin-piperaquine (DP)

## Key facts

- **NCT ID:** NCT02009215
- **Lead sponsor:** London School of Hygiene and Tropical Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 10746 (ACTUAL)
- **Last updated:** 2015-09-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02009215

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02009215, "School-Based Treatment With ACT to Reduce Transmission". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT02009215. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*